These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 34937564)

  • 1. Prognostic biomarker SMARCC1 and its association with immune infiltrates in hepatocellular carcinoma.
    Cai X; Zhou J; Deng J; Chen Z
    Cancer Cell Int; 2021 Dec; 21(1):701. PubMed ID: 34937564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin-dependent kinase 19 upregulation correlates with an unfavorable prognosis in hepatocellular carcinoma.
    Cai X; Deng J; Zhou J; Cai H; Chen Z
    BMC Gastroenterol; 2021 Oct; 21(1):377. PubMed ID: 34649520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UHRF1 Could Be a Prognostic Biomarker and Correlated with Immune Cell Infiltration in Hepatocellular Carcinoma.
    Li D; Chen B; Zeng Y; Wang H
    Int J Gen Med; 2021; 14():6769-6776. PubMed ID: 34675635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDT1 Is a Novel Prognostic and Predictive Biomarkers for Hepatocellular Carcinoma.
    Cai C; Zhang Y; Hu X; Hu W; Yang S; Qiu H; Chu T
    Front Oncol; 2021; 11():721644. PubMed ID: 34631549
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Liu S; Zhao W; Li X; Zhang L; Gao Y; Peng Q; Du C; Jiang N
    Front Oncol; 2021; 11():713017. PubMed ID: 34595113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma.
    Wang X; He S; Zheng X; Huang S; Chen H; Chen H; Luo W; Guo Z; He X; Zhao Q
    BMC Cancer; 2021 Sep; 21(1):1001. PubMed ID: 34493238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ASRGL1 Correlates With Immune Cell Infiltration in Hepatocellular Carcinoma and Can Serve as a Prognostic Biomarker.
    Xue C; Gao P; Cui X; Zhang X; Lei J; Li R; Zhu C; Qin X
    Front Oncol; 2021; 11():680070. PubMed ID: 34249720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RAB6B is a potential prognostic marker and correlated with the remolding of tumor immune microenvironment in hepatocellular carcinoma.
    Peng H; Zhu E; Wang J; Du X; Wang C; Yang M; Zhang Y
    Front Pharmacol; 2022; 13():989655. PubMed ID: 36120364
    [No Abstract]   [Full Text] [Related]  

  • 9. Exploring the Prognostic Value, Immune Implication and Biological Function of
    Huang Y; Huang S; Ma L; Wang Y; Wang X; Xiao L; Qin W; Li L; Yuan X
    Front Immunol; 2021; 12():723293. PubMed ID: 34899687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of SMARCC1 predicts poor prognosis in gastric cancer patients.
    Liu S; Cao X; Wu S
    Am J Cancer Res; 2022; 12(9):4428-4438. PubMed ID: 36225646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of prognostic value, relationship to cell cycle, immune infiltration and m6A modification of ZSCAN20 in hepatocellular carcinoma.
    Jiayu F; Jiang Y; Zhou X; Zhou M; Pan J; Ke Y; Zhen J; Huang D; Jiang W
    Aging (Albany NY); 2022 Dec; 14(23):9550-9578. PubMed ID: 36462500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpressed SNRPB/D1/D3/E/F/G correlate with poor survival and immune infiltration in hepatocellular carcinoma.
    Li FP; Liu GH; Zhang XQ; Kong WJ; Mei J; Wang M; Dai YH
    Am J Transl Res; 2022; 14(6):4207-4228. PubMed ID: 35836882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic analysis of the expression profile and prognostic significance of m6A regulators and PD-L1 in hepatocellular carcinoma.
    Kong F; Wang K; Wang L
    Discov Oncol; 2022 Nov; 13(1):131. PubMed ID: 36434140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of Taspase 1 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma.
    Jiang J; Liu B; Liu R; Yang W
    Cancer Manag Res; 2021; 13():2517-2537. PubMed ID: 33758547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ALDH2 is a prognostic biomarker and related with immune infiltrates in HCC.
    Yao S; Yin X; Chen T; Chen W; Zuo H; Bi Z; Zhang X; Jing Y; Pang L; Cheng H
    Am J Cancer Res; 2021; 11(11):5319-5337. PubMed ID: 34873463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression and prognostic value of GLYATL1 and its potential role in hepatocellular carcinoma.
    Guan R; Hong W; Huang J; Peng T; Zhao Z; Lin Y; Yu M; Jian Z
    J Gastrointest Oncol; 2020 Dec; 11(6):1305-1321. PubMed ID: 33457003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study on the expression of TOP2A in hepatocellular carcinoma and its relationship with patient prognosis.
    Meng J; Wei Y; Deng Q; Li L; Li X
    Cancer Cell Int; 2022 Jan; 22(1):29. PubMed ID: 35033076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Hepatic Cancer Stem Cells (HCSCs) Markers Correlated With Immune Infiltrates Reveal Prognostic Significance of Hepatocellular Carcinoma.
    Sang X; Wu F; Wu D; Lin S; Li J; Zhao N; Chen X; Xu A
    Front Genet; 2020; 11():112. PubMed ID: 32184801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of zinc finger protein 2, a prognostic biomarker, with immune infiltrates in liver cancer.
    Sun L; Lin Y; Wang G; Zhang L; Hu L; Lu Z
    Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33439969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exonuclease 1 is a Potential Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma.
    Ma J; Jin J; Lu H; Zhang J; Li Y; Cai X
    Front Mol Biosci; 2022; 9():889414. PubMed ID: 35769911
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.